KH 004
Alternative Names: KH-004Latest Information Update: 05 Nov 2024
Price :
$50 *
At a glance
- Originator Kadence Bio
- Class Alkaloids; Mood stabilisers
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Mood disorders
Most Recent Events
- 05 Nov 2024 Early research in Mood disorders in United Kingdom (unspecified route) prior to November 2024 (Kadence Bio pipeline, November 2024)